Key facts
- MicroTransponder’s last known valuation is $225.0M (Mar 2025).
- It has raised $207.3M across 9 recorded rounds; the latest was Early Stage VC ($32.5M) in Mar 2025.
- Notable investors include MedTech Innovator, Osage University Partners, Revelation Partners, Gilde Healthcare, Longitude Capital — 18 tracked in total.
- MicroTransponder has filed 13 Form Ds with the SEC since 2010, most recently Mar 2025 ($32.5M sold to 19 investors).
- Status: In IPO Registration.
- ·Post-money valuations for all 9 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for MicroTransponder
Funding rounds
9 roundsAbout MicroTransponder
Developer of an implantable neurostimulation device designed to aid stroke recovery and other neurological disorders. The company's device incorporates paired vagus nerve stimulation and wireless technology to deliver targeted electrical impulses, enhancing neuroplasticity and restoring motor function in post-stroke patients, enabling healthcare practitioners to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2007
- Employees
- 191
- Website
- mobia.com/
- Ownership
- In IPO Registration
MicroTransponder doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MicroTransponder shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MicroTransponder in its N-PORT filings yet. We sweep new filings monthly.